atazanavir sulfate 100 MG Oral Capsule

RxCUI
402245
RxNorm name
atazanavir sulfate 100 MG Oral Capsule
Display name
atazanavir sulfate 100 MG Oral Capsule
Full name
atazanavir sulfate 100 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Atazanavir SulfateATAZANAVIRAurobindo Pharma Limited7fbea274-d6b5-4faa-bbf0-05fefab421142025-08-06Warnings, Adverse reactionsExact identifier
rxcui: 402245

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7fbea274-d6b5-4faa-bbf0-05fefab42114atazanavir sulfate 100 MG Oral CapsulePSN8These highlights do not include all the information needed to use ATAZANAVIR CAPSULES safely and effectively. See full prescribing information for ATAZANAVIR CAPSULES. ATAZANAVIR capsules, for oral use Initial U.S. Approval: 200320250806
7fbea274-d6b5-4faa-bbf0-05fefab42114atazanavir 100 MG (as atazanavir sulfate 113.9 MG) Oral CapsuleSY8These highlights do not include all the information needed to use ATAZANAVIR CAPSULES safely and effectively. See full prescribing information for ATAZANAVIR CAPSULES. ATAZANAVIR capsules, for oral use Initial U.S. Approval: 200320250806
7fbea274-d6b5-4faa-bbf0-05fefab42114atazanavir 100 MG Oral CapsuleSCD8These highlights do not include all the information needed to use ATAZANAVIR CAPSULES safely and effectively. See full prescribing information for ATAZANAVIR CAPSULES. ATAZANAVIR capsules, for oral use Initial U.S. Approval: 200320250806